Fact CheckerSign in

NCT07288333RecruitingPhase 2

Evaluation of NBI-1117570 in Inpatient Adults With Schizophrenia

A Phase 2a, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of NBI-1117570 in Adults With Schizophrenia Who Warrant Inpatient Hospitalization

Source: ClinicalTrials.gov · Last updated 22 Jul 2026

Brief summary (registry, in English)

The primary objective for this study is to evaluate the efficacy of NBI-1117570 compared with placebo on improving behavioral and psychological symptoms of schizophrenia in adults who warrant inpatient hospitalization.

Status (registry)
Recruiting
Phase (registry)
Phase 2
Study type
Interventional
Enrollment
120 (estimated)
First submitted
15 Dec 2025
Start date
16 Feb 2026
Primary completion date
31 Aug 2027
Lead sponsor
Neurocrine Biosciences
NCT number
NCT07288333
EU CT number
2025-521868-35-00

What you commit to

  • Study type: Interventional · Phase 2
  • Planned participants: 120
  • From 16 Feb 2026 to the primary completion date, 31 Aug 2027
  • 15 sites in 5 countries
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Currently taking prohibited medications.

Other illness

  • History of epilepsy, seizures, or convulsions.
  • Has orthostatic hypotension, or history of pulmonary hypertension, obstructive coronary artery disease, hypertrophic cardiomyopathy, myocardial infarction, coronary artery revascularization, heart failure, left ventricular hypertrophy, moderate or severe cardiac valvopathy, or other cardiovascular conditions or measures that would preclude participation.

Other

  • Considered to be at imminent risk of suicide or injury to self or others.
  • Pregnant or lactating.
    • Note: Additional inclusion/exclusion criteria may apply, per protocol.

Who the study is looking for

  • 18 to 55 years of age
  • Primary diagnosis of schizophrenia ≥1 year before screening.
  • Participant is experiencing an acute exacerbation or relapse of symptoms with onset less than 2 months before screening and currently requires hospitalization.
  • Participant must have had a positive response to at least 1 antipsychotic therapy (other than clozapine) for the treatment of a prior acute relapse.

Age in the registry: 18 years to 55 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (15)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Multiprofile Hospital For Active Treatment Dr. Hristo Stambolski EOOD
Coordinator of this site? Confirm its status
KazanlikBulgariaRecruiting
State Psychiatric Hospital Pazardzhik
Coordinator of this site? Confirm its status
PazardzhikBulgariaRecruiting
University Multiprofile Hospital for Active Treatment Dr Georgi Stranski EAD
Coordinator of this site? Confirm its status
PlevenBulgariaRecruiting
Multiprofile Hospital For Active Treatment - Targovishte AD
Coordinator of this site? Confirm its status
TargovishteBulgariaRecruiting
Neurocrine Clinical Site
Coordinator of this site? Confirm its status
LondonUnited KingdomRecruiting
Neurocrine Clinical Site
Coordinator of this site? Confirm its status
OxfordUnited KingdomRecruiting
Clinic for psychiatry Sveti Ivan
Coordinator of this site? Confirm its status
Grad ZagrebCroatiaNot yet recruiting
Klinika za psihijatriju Vrapce
Coordinator of this site? Confirm its status
Grad ZagrebCroatiaNot yet recruiting
Uniwersytecki Szpital Kliniczny w Bialymstoku
Coordinator of this site? Confirm its status
BialystokPolandNot yet recruiting
Uniwersyteckie Centrum Kliniczne
Coordinator of this site? Confirm its status
GdanskPolandNot yet recruiting
Samodzielny Publiczny Zaklad Opieki Zdrowotnej Centralny Szpital Kliniczny Uniwersytetu Medycznego W Lodzi
Coordinator of this site? Confirm its status
LodzPolandNot yet recruiting
Centrum Medyczne HCP Sp. z o.o.
Coordinator of this site? Confirm its status
PoznanPolandNot yet recruiting
Spitalul Clinic de Psihiatrie Prof Dr Alexandru Obregia
Coordinator of this site? Confirm its status
BucharestRomaniaRecruiting
Institutul De Psihiatrie Socola Iasi
Coordinator of this site? Confirm its status
JassiRomaniaRecruiting
Spitalul Clinic Judeţean Mureş
Coordinator of this site? Confirm its status
Târgu MureşRomaniaRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.